Cochlear’s DKK 850 Million Acquisition of Oticon Medical

Walder Wyss AG advised Demant A/S and its lead counsel Please.

Following a strategic review, Demant A/S has decided to discontinue its Hearing Implant business area and announced the intention to sell Oticon Medical to Cochlear Limited, a market leader in implantable hearing.

In the review of options for the future, it was of utmost importance to find a professional counterpart, who would commit to ensuring the best lifelong support of existing customers and patients.

Cochlear has committed to provide ongoing support for the entire patient base, which include cochlear implants (CI) and bone anchored hearing systems (BAHS). The total consideration is DKK 850 million.

The Walder Wyss team comprised by Urs P. Gnos (Picture – Partner, Corporate/M&A) and Christian Hagen (Managing Associate, Corporate/M&A).

Involved fees earner: Urs Gnos – Walder Wyss Ltd.; Christian Hagen – Walder Wyss Ltd.;

Law Firms: Walder Wyss Ltd.;

Clients: Demant;

Federica Tiefenthaler

Author: Federica Tiefenthaler